Login
Home
Charts
Search
Watchlist
Products

Radix Industries (India) Ltd

RADIXIND·BSE
133.70+2.96%Wed, 23 Sept '26 15:14

Radix Industries (India) Ltd

RADIXIND
BSE
133.70
+2.96%
|Wed, 23 Sept '26 15:14
SOICxStockScans Reports
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
201Cr
Close
Close Price
133.70
Industry
Industry
Personal Care
PE
Price To Earnings
68.56
PS
Price To Sales
4.38
Revenue
Revenue
46Cr
Rev Gr TTM
Revenue Growth TTM
-7.04%
PAT Gr TTM
PAT Growth TTM
8.09%

Quarterly Results

Standalone
Numbers
Percentage
QuarterSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue
RevenueCr
1088713161281217133
Growth YoY
Revenue Growth YoY%
115.1-15.7-12.9-1.835.692.454.915.2-9.311.55.2-58.1
Expenses
ExpensesCr
977613141171116123
Operating Profit
Operating ProfitCr
111111111111
OPM
OPM%
6.213.612.011.04.89.37.810.18.38.34.316.9
Other Income
Other IncomeCr
000000000100
Interest Expense
Interest ExpenseCr
000000000000
Depreciation
DepreciationCr
000000000000
PBT
PBTCr
111111111210
Tax
TaxCr
000000000000
PAT
PATCr
011101111100
Growth YoY
PAT Growth YoY%
12.545.638.315.2-6.749.33.118.969.042.0-32.8-42.9
NPM
NPM%
4.68.28.27.63.16.45.57.85.98.13.510.7
EPS
EPS
0.30.50.40.40.30.70.50.40.50.90.30.2
QuarterSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue
RevenueCr
1088713161281217133
Growth YoY
Revenue Growth YoY%
115.1-15.7-12.9-1.835.692.454.915.2-9.311.55.2-58.1
Expenses
ExpensesCr
977613141171116123
Operating Profit
Operating ProfitCr
111111111111
OPM
OPM%
6.213.612.011.04.89.37.810.18.38.34.316.9
Other Income
Other IncomeCr
000000000100
Interest Expense
Interest ExpenseCr
000000000000
Depreciation
DepreciationCr
000000000000
PBT
PBTCr
111111111210
Tax
TaxCr
000000000000
PAT
PATCr
011101111100
Growth YoY
PAT Growth YoY%
12.545.638.315.2-6.749.33.118.969.042.0-32.8-42.9
NPM
NPM%
4.68.28.27.63.16.45.57.85.98.13.510.7
EPS
EPS
0.30.50.40.40.30.70.50.40.50.90.30.2

Profit & Loss

Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
301412111128252633485146
Growth
Revenue Growth%
-46.2-54.0-13.0-11.3-1.1160.0-7.63.325.746.24.7-7.0
Expenses
ExpensesCr
2612109925232430444742
Operating Profit
Operating ProfitCr
422222223444
OPM
OPM%
13.016.718.219.318.78.09.69.110.17.97.67.8
Other Income
Other IncomeCr
000000000011
Interest Expense
Interest ExpenseCr
100000000000
Depreciation
DepreciationCr
000000000000
PBT
PBTCr
322222223444
Tax
TaxCr
110010111111
PAT
PATCr
211111222333
Growth
PAT Growth%
-58.5-38.30.6-1.3-4.518.07.31.446.217.621.78.1
NPM
NPM%
6.89.110.511.711.35.15.95.86.85.46.36.4
EPS
EPS
1.40.80.80.60.80.91.01.01.51.82.11.9
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
301412111128252633485146
Growth
Revenue Growth%
-46.2-54.0-13.0-11.3-1.1160.0-7.63.325.746.24.7-7.0
Expenses
ExpensesCr
2612109925232430444742
Operating Profit
Operating ProfitCr
422222223444
OPM
OPM%
13.016.718.219.318.78.09.69.110.17.97.67.8
Other Income
Other IncomeCr
000000000011
Interest Expense
Interest ExpenseCr
100000000000
Depreciation
DepreciationCr
000000000000
PBT
PBTCr
322222223444
Tax
TaxCr
110010111111
PAT
PATCr
211111222333
Growth
PAT Growth%
-58.5-38.30.6-1.3-4.518.07.31.446.217.621.78.1
NPM
NPM%
6.89.110.511.711.35.15.95.86.85.46.36.4
EPS
EPS
1.40.80.80.60.80.91.01.01.51.82.11.9

Balance Sheet

Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
Equity CapitalCr
1010101015151515151515
Reserves
ReservesCr
57772233468
Current Liabilities
Current LiabilitiesCr
454761072100
Non Current Liabilities
Non Current LiabilitiesCr
00000021000
Total Liabilities
Total LiabilitiesCr
2022202423282721202124
Current Assets
Current AssetsCr
2022202423272618171821
Non Current Assets
Non Current AssetsCr
00000113333
Total Assets
Total AssetsCr
2022202423282721202124
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
Equity CapitalCr
1010101015151515151515
Reserves
ReservesCr
57772233468
Current Liabilities
Current LiabilitiesCr
454761072100
Non Current Liabilities
Non Current LiabilitiesCr
00000021000
Total Liabilities
Total LiabilitiesCr
2022202423282721202124
Current Assets
Current AssetsCr
2022202423272618171821
Non Current Assets
Non Current AssetsCr
00000113333
Total Assets
Total AssetsCr
2022202423282721202124

Cash Flow

Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
10-23-12-358487
Investing Cash Flow
Investing Cash FlowCr
000000-1-1-101
Financing Cash Flow
Financing Cash FlowCr
-101-32-23-3-8-4-2-1
Net Cash Flow
Net Cash FlowCr
0000-102-2067
Free Cash Flow
Free Cash FlowCr
10-23-11-347377
CFO To PAT
CFO To PAT%
496.1-123.0253.7-113.3126.3-185.0328.1505.0186.6286.6205.5
CFO To EBITDA
CFO To EBITDA%
257.9-66.6145.8-68.575.9-118.2202.3324.2125.0197.1171.8
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
10-23-12-358487
Investing Cash Flow
Investing Cash FlowCr
000000-1-1-101
Financing Cash Flow
Financing Cash FlowCr
-101-32-23-3-8-4-2-1
Net Cash Flow
Net Cash FlowCr
0000-102-2067
Free Cash Flow
Free Cash FlowCr
10-23-11-347377
CFO To PAT
CFO To PAT%
496.1-123.0253.7-113.3126.3-185.0328.1505.0186.6286.6205.5
CFO To EBITDA
CFO To EBITDA%
257.9-66.6145.8-68.575.9-118.2202.3324.2125.0197.1171.8

Ratios

Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
1227763769641121118228246321201
Price To Earnings
Price To Earnings
66.761.649.660.681.328.880.577.0102.193.5100.368.6
Price To Sales
Price To Sales
4.05.65.27.19.11.54.84.56.95.16.34.4
Price To Book
Price To Book
7.94.63.74.55.72.36.66.512.011.813.88.6
EV To EBITDA
EV To EBITDA
31.835.329.939.751.623.052.250.568.662.880.650.4
Profitability Ratios
Profitability Ratios
GPM
GPM%
15.021.424.927.631.511.613.812.812.910.19.09.0
OPM
OPM%
13.016.718.219.318.78.09.69.110.17.97.67.8
NPM
NPM%
6.89.110.511.711.35.15.95.86.85.46.36.4
ROCE
ROCE%
20.810.410.58.58.57.99.011.217.117.918.618.6
ROE
ROE%
13.27.57.57.47.18.18.38.411.812.613.713.7
ROA
ROA%
10.35.76.25.35.25.15.67.311.312.413.613.6
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
1227763769641121118228246321201
Price To Earnings
Price To Earnings
66.761.649.660.681.328.880.577.0102.193.5100.368.6
Price To Sales
Price To Sales
4.05.65.27.19.11.54.84.56.95.16.34.4
Price To Book
Price To Book
7.94.63.74.55.72.36.66.512.011.813.88.6
EV To EBITDA
EV To EBITDA
31.835.329.939.751.623.052.250.568.662.880.650.4
Profitability Ratios
Profitability Ratios
GPM
GPM%
15.021.424.927.631.511.613.812.812.910.19.09.0
OPM
OPM%
13.016.718.219.318.78.09.69.110.17.97.67.8
NPM
NPM%
6.89.110.511.711.35.15.95.86.85.46.36.4
ROCE
ROCE%
20.810.410.58.58.57.99.011.217.117.918.618.6
ROE
ROE%
13.27.57.57.47.18.18.38.411.812.613.713.7
ROA
ROA%
10.35.76.25.35.25.15.67.311.312.413.613.6
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Radix Industries is a manufacturer and exporter of finished human hair wigs and extensions, built on India’s unmatched supply of the raw material the world’s wig-makers want most. The business was shaped by Managing Director G. Raghu Rama Raju, who spent decades in the human hair export trade - first as an executive at a pioneer firm, then through his own export partnership - before Radix itself entered the product line in FY 2012-13. The recurring logic is simple: buy raw human hair in bulk whenever it becomes available, process it into finished goods at a single plant in Andhra Pradesh, and sell to overseas buyers who prize Asian hair above all other types. # Business segments A single engine - human hair wigs and extensions, sold to export markets and supplemented by occasional trading of raw material - run from one factory with no subsidiaries. ## 1. Human hair products: wigs and extensions for the world **The company turns Indian human hair into finished wigs and extensions, then sells them to buyers across a dozen countries - a single-product export house built on a raw material that cannot be ordered, only stockpiled.** - **The raw material is the moat** - Asian hair grows fastest and has the greatest elasticity of any hair type, making it the most preferred for wigs worldwide, and India is one of only two primary sources alongside China. Hair from rural donors is especially prized because it has not been exposed to harsh chemicals or dyes, so finished products command premium pricing over synthetic alternatives. - **Bought in bulk, not on demand** - human hair cannot be procured just-in-time; the company must purchase large quantities whenever stocks become available, which ties up heavy capital in inventory. Raw material inventories have consistently been the largest asset on the balance sheet, and inventory turnover stretched to 277 days in FY23 and 350 days in FY22 - the business is fundamentally a working-capital play on a scarce natural input. - **One plant, many markets** - all manufacturing happens at a single facility in Tanuku, Andhra Pradesh, co-located with the registered office, where the company has been steadily building out capacity with capital work-in-progress rising from roughly ₹81 lakhs in FY22 to ₹228 lakhs in FY24 before completion. From that one plant, finished goods reach customers in China, Brazil, Spain, Korea, the UK, Hong Kong, Indonesia, Italy, Austria, Germany and others. - **Synthetic hair is the defeated rival** - the main historical competitive threat was synthetic wigs, but those products have lost favour with consumers because synthetic hair has been linked to allergic reactions and cancer concerns, shifting demand decisively toward human hair. The company still faces competition from an unorganized sector and notes that medical alternatives like hair transplants could act as a long-term restraint, but for now the trend runs in its favour. - **Raw material trading fills the gaps** - alongside finished products, the company occasionally sells raw human hair directly, though this is a minor and variable activity: raw material sales contributed about 45% of total sales in FY21 but dwindled to negligible amounts in subsequent periods, suggesting the company sells raw stock when inventory strategy or market conditions warrant it rather than as a steady second line of business. # Group structure and partners **A tightly held family enterprise with no subsidiaries today, though a US marketing subsidiary was approved in mid-2025 - the first step beyond a pure standalone model.** - The promoters - Managing Director G. Raghu Rama Raju, his spouse G. Parvathi, and one other family member - together held nearly 75% of the company as of FY25, with the MD alone holding close to 62%. The MD’s wife, a Non-Executive Director, oversees day-to-day administration and production, while his brother serves as Director and CFO - the entire senior leadership is family. - The company has operated with no subsidiaries, associates, or joint ventures throughout its history, but on 4 August 2025 the board approved incorporating a wholly owned subsidiary in the United States - to be called Radix Inc. - with a nominal capital of USD 1,000, focused purely on marketing, distribution and sale of human hair products in the American market. - The registered office and factory premises are leased from a related party, Diamond Drop Property Holdings (India) Private Limited - in which there is a common director - at a fixed rent of ₹35,000 per month under a 10-year lease that began in February 2021. - The Managing Director also leads a separate company, M/s Arqube Industries (India) Limited - another 100% Export Oriented Unit in the same human hair industry - which was the corporate successor to the original partnership firm he founded in 1999, meaning the family’s involvement in hair exports predates Radix itself by over a decade.

Documents — Radix Industries (India) Ltd

  • Q1 FY2027 Quarterly Result (Jun 2026, PDF): https://www.stockscans.in/document/ikqi93p8gcnri9bazoi9ymh1.pdf
  • Q4 FY2026 Quarterly Result (Mar 2026, PDF): https://www.stockscans.in/document/4nlhova411vc77npcz8nrww8.pdf
  • Q3 FY2026 Quarterly Result (Dec 2025, PDF): https://www.stockscans.in/document/rcv73z48gjv7ug9j5up1lrov.pdf
  • Q2 FY2026 Quarterly Result (Sep 2025, PDF): https://www.stockscans.in/document/fx8fmgexu7yyh778bryre0cb.pdf
  • Q1 FY2026 Quarterly Result (Jun 2025, PDF): https://www.stockscans.in/document/hab9lzl32kq3sm53h1ac37wx.pdf
  • Q4 FY2025 Quarterly Result (Mar 2025, PDF): https://www.stockscans.in/document/xxy0p7vwueyn1qzyk0mrks3b.pdf
  • Q3 FY2025 Quarterly Result (Dec 2024, PDF): https://www.stockscans.in/document/gk7ax49r67pttwa91kvwfs39.pdf
  • Q2 FY2025 Quarterly Result (Sep 2024, PDF): https://www.stockscans.in/document/hsrisnrnnj0l9lev6hf1l821.pdf
  • FY2026 Annual Report (PDF): https://www.stockscans.in/document/om3ns6gd318fo5r22b9s6f67.pdf
  • FY2025 Annual Report (PDF): https://www.stockscans.in/document/uswcjxd1aqxf8xsv149k6ydw.pdf
  • FY2024 Annual Report (PDF): https://www.stockscans.in/document/l8b9nf0ublrqbt93fe249glf.pdf
  • FY2023 Annual Report (PDF): https://www.stockscans.in/document/15eshgwndy4tuuhjrcuks7fh.pdf
  • FY2022 Annual Report (PDF): https://www.stockscans.in/document/i4e7a04te30kddp0n31qdz47.pdf
  • FY2021 Annual Report (PDF): https://www.stockscans.in/document/un5lm2t2n65x5kzvd0hjpw5h.pdf
  • FY2020 Annual Report (PDF): https://www.stockscans.in/document/qblp5np9pvslu52rx3ein01j.pdf